Mammalian telomeres contain a single-stranded 3 0 overhang that is thought to mediate telomere protection. Here we identify the TRF2-interacting factor Apollo as a nuclease that contributes to the generation/maintenance of this overhang. The function of mouse Apollo was determined using Cre-mediated gene deletion, complementation with Apollo mutants, and the TRF2-F120A mutant that cannot bind Apollo. Cells lacking Apollo activated the ATM kinase at their telomeres in S phase and showed leading-end telomere fusions. These telomere dysfunction phenotypes were accompanied by a reduction in the telomeric overhang signal. The telomeric functions of Apollo required its TRF2-interaction and nuclease motifs. Thus, TRF2 recruits the Apollo nuclease to process telomere ends synthesized by leading-strand DNA synthesis, thereby creating a terminal structure that avoids ATM activation and resists end-joining. These data establish that the telomeric overhang is required for the protection of telomeres from the DNA damage response.
INTRODUCTION
Mammalian telomeres terminate in a 50-400 nt single-stranded 3 0 overhang that is assumed to have a crucial role in end protection (Makarov et al., 1997; McElligott and Wellinger, 1997; Wright et al., 1997) . This G-rich overhang can serve as the primer for telomerase, which synthesizes the telomeric TTAGGG repeats and maintains telomere length homeostasis in S phase (Greider and Blackburn, 1987) . Furthermore, strand invasion of the G-rich overhang into the duplex region of the telomere has been proposed to protect chromosome ends (Griffith et al., 1999) . This structure, known as the t-loop, would presumably prevent loading of the Ku70/80 heterodimer and the MRN (Mre11, Rad50, Nbs1) complex, thereby blocking nonhomologous endjoining (NHEJ) and ATM signaling, respectively (reviewed in de Lange, 2009 ). The single-stranded G-rich repeats also function as binding sites for the POT1 proteins, which prevent the activation of ATR, protect against postreplicative fusions of sister chromatids, and repress homologous recombination between sister telomeres (Hockemeyer et al., 2006; Lazzerini Denchi and de Lange, 2007; Wu et al., 2006; Palm et al., 2009) .
The telomeric overhang is generated during replication independently of telomerase (Hemann and Greider, 1999) , and its length correlates with the rate of telomere shortening in human cells lacking telomerase (Huffman et al., 2000) . However, the factors involved in the generation of the telomeric overhangs have not been identified. The degradation of the terminal RNA primer used in lagging-strand DNA synthesis has been proposed to generate a 3 0 overhang at lagging-end telomeres, resulting in the end-replication problem (Watson, 1972) . However, evidence of telomeric overhangs at ends replicated by both leading-and lagging-strand DNA synthesis in human cells suggests an additional mechanism(s) of overhang generation (Makarov et al., 1997) . Specifically, the 5 0 to 3 0 progression of leading-strand DNA synthesis necessitates resection of the parental 5 0 ends to generate 3 0 overhangs at leading-end telomeres. Recent studies have suggested a role for the shelterin component TRF2 in overhang generation at leading-end telomeres. Telomeres with compromised TRF2 activate the MRN-dependent ATM kinase pathway and undergo NHEJ, generating chromosome end fusions that are promoted by ATM signaling (van Steensel et al., 1998; Celli and de Lange, 2005; Lazzerini Denchi and de Lange, 2007; Dimitrova and de Lange, 2009; Deng et al., 2009; Attwooll et al., 2009 ). When TRF2 is deleted, the telomeric overhang signal is rapidly lost, presumably as a consequence of the frequent NHEJ events (Celli and de Lange, 2005) . However, in the absence of Nbs1, TRF2 deletion still induces significant overhang loss, even though telomeric NHEJ events are infrequent and limited to leading-end telomeres (Dimitrova and de Lange, 2009 ). These observations led to the proposal that TRF2 recruits or activates a nuclease that generates the 3 0 overhang at leading-end telomeres (Dimitrova and de Lange, 2009 ). In the absence of TRF2, the MRN/ATM pathway was proposed to induce resection at the unprotected ends, thereby providing an alternative means of generating overhangs at the leadingend telomeres. Consistent with this proposal, the fusion of leading-end telomeres is a highly specific phenotype associated with TRF2 deletion from MRN-or ATM-deficient cells (Dimitrova and de Lange, 2009; Attwooll et al., 2009) .
Among the factors recruited to telomeres by TRF2, one candidate nuclease is Apollo/SNM1B. Apollo belongs to the mammalian SNM1/Pso2 family of nucleases, which also includes SNM1A and Artemis/SNM1C. SNM1A contributes to the repair of DNA interstrand crosslinks (ICLs) (Demuth et al., 2004; Dronkert et al., 2000) , lesions that block DNA replication and transcription (reviewed in Dominski, 2007) . Similarly, knockdown of Apollo/SNM1B in human cells results in hypersensitivity to ICL-inducing agents (Demuth et al., 2004; Bae et al., 2008) . In contrast, Artemis/SNM1C functions as an endonuclease to remove hairpins from coding ends during V(D)J recombination (reviewed in de Villartay, 2009) and has been suggested to contribute to homology-directed repair (HDR) and NHEJ of a subset of DSBs by removing structures that block repair reactions (Kurosawa et al., 2008; Beucher et al., 2009) .
Apollo is the only member of the SNM1/Pso2 family known to function as a shelterin accessory factor. Unlike core components of shelterin, shelterin accessory factors are not abundant at telo- meres; they are often not observed at all telomeres and/or show a transient telomere association; and they function at nontelomeric sites, most often in the DNA damage response (reviewed in Palm and de Lange, 2008) . Apollo is recruited to telomeres through a C-terminal YxLxP motif that mediates its interaction with a common protein-docking site surrounding F120 of TRF2 . Knockdown experiments have implicated human Apollo in the protection of telomeres in S phase (van Overbeek and de Lange, 2006; Lenain et al., 2006) . Here we use conditional gene deletion and dissociation-of-function alleles to determine the role of the Apollo nuclease at mouse telomeres. We identify a function for Apollo in maintaining the telomeric overhang and preventing fusions of newly synthesized leading-end telomeres.
RESULTS

Conditional Deletion of Apollo
To generate a conditional gene deletion system in mouse embryo fibroblasts (MEFs), the Apollo gene (Dclre1b, chromosome 3) was modified by gene targeting, resulting in a floxed allele (Apollo F ) that contained loxP Cre recombinase target sites flanking exons 2 and 3 ( Figure 1A ). Deletion of exons 2 and 3 is predicted to result in out-of-frame splicing of exon 1 to exon 4, interrupting the Apollo ORF at amino acid position 67. This strategy was favored over conditional deletion of exon 1, which might affect the neighboring Ap4b1 gene ( Figure 1A) . Apollo F/F embryos (E13.5), derived from Apollo F/+ mouse intercrosses, were used to establish SV40 large T antigen (SV40-LT) immortalized MEFs. Transient expression of Cre recombinase in these cells resulted in the expected deletion of the Apollo gene and concomitant loss of the full-length Apollo mRNA, whereas the Ap4b1 transcript was not affected ( Figures 1B and 1C) . Cre treatment of the Apollo F/F MEFs resulted in a slight proliferation defect that was due to the absence of Apollo, since it was largely rescued by expression of the wild-type protein (see Figure S1A available online). The cell-cycle profile of SV40-LT Apollo F/F MEFs showed an elevated 4N peak due to a high basal level of tetraploid cells, which is a common phenomenon in immortalized MEFs. Cre-mediated deletion of Apollo caused a slight increase in tetraploid cells, reflected in an increase in the 8N peak, but did not significantly alter the cell-cycle profile or S phase index, as measured by BrdU incorporation ( Figure S1B ). Thus, deletion of Apollo does not immediately block proliferation of immortalized MEFs, allowing the evaluation of Apollo function in these cells.
Apollo Mutants
In order to assess the telomere-specific functions of Apollo, we generated an Apollo allele deficient for binding to telomeres (ApolloDTRF2) ( Figures 1D-1F and Figure S1C ). Despite a previous report documenting that Apollo is unstable when not bound to TRF2 (Freibaum and Counter, 2008) , we observed that both human and mouse ApolloDTRF2 were expressed at the same level as the wild-type protein ( Figure 1E , Figures S1D-S1F). Deletion of the YLLTP TRF2 binding site abolished the interaction of Apollo with TRF2 and generated a protein that was incapable of accumulating at telomeres ( Figure 1F , Figure S1C ).
To evaluate whether the function of Apollo depends on its nuclease activity, we generated a nuclease-deficient allele of Apollo, Apollo-ND, by mutating the HxHxDH motif in the metallo-b-lactamase domain as well as a highly conserved histidine in the b-CASP domain ( Figures 1D-1F ). Both the HxHxDH motif and histidine 230 are conserved in Artemis and required for the endonucleolytic activity of this closely related SNM1 nuclease (Callebaut et al., 2002; Pannicke et al., 2004; de Villartay et al., 2009) . Consistent with the preservation of the TRF2-interacting site in Apollo-ND, the nuclease-deficient protein associated with TRF2 and localized to telomeres ( Figure 1F and Figure S1C ). Based on IF analysis (n > 100 nuclei), both the wild-type and Apollo-ND alleles were detectable at approximately half the telomeres in the cells. Since Apollo is not as abundant at telomeres as the shelterin components, it is possible that both wild-type Apollo and Apollo-ND localize to all telomeres but escape detection because of their low abundance.
Apollo Protects Telomeres from Activating the ATM Kinase Deletion of Apollo resulted in the induction of a moderate DNA damage response. Approximately one-third of the cells showed telomere dysfunction-induced foci (TIFs; Takai et al., 2003) at a subset ($10%) of the telomeres (Figure 2 ). The TIF response was accompanied by phosphorylation of Chk2, a target of the ATM kinase ( Figure 2B ). Consistent with the Chk2 phosphorylation, the TIF response was ablated when cells were treated with an shRNA to the ATM kinase but unaffected by knockdown of ATR ( Figures 2C-2E and Figure S2 ). Thus, deletion of Apollo elicits ATM kinase signaling at a subset of the telomeres in a fraction of the cells.
Whereas wild-type Apollo effectively repressed TIF formation and Chk2 phosphorylation in the Cre-treated Apollo F/F MEFs, ApolloDTRF2 was unable to prevent the DNA damage response associated with Apollo loss in mouse and in human cells ( Figures  2A, 2B , and 1D; Figures S1D-S1F ). In addition, Apollo-ND failed to prevent activation of ATM signaling at telomeres. Both mutant forms of Apollo induced a level of Chk2 phosphorylation similar to that in the absence of Apollo ( Figure 2B and data not shown). Therefore, repression of ATM signaling at telomeres appears to require an Apollo that both is nuclease proficient and localizes to telomeres.
ATM Activation in the Absence of Apollo Occurs in Early/Mid S Phase
Since the TIF response was observed in approximately one-third of the Apollo-deficient cells, we investigated the cell-cycle dependence of this DNA damage response. We developed a method for isolating G1, S, and late S/G2 cells based on the fluorescence ubiquitination-based cell-cycle indicator (FUCCI) system (Sakaue-Sawano et al., 2008) ( Figure 3A , Figure S3A ). FUCCI uses fluorescently tagged Cdt1 (expressed in G1 and degraded in early S phase) and Geminin (expressed in S/G2 and degraded in mitosis) to mark cells in different phases of the cell cycle. With this approach, G1, S, and S/G2 populations are isolated by FACS sorting, avoiding the disadvantages of synchronizing cells with drug treatments. For the FUCCI-sorting method, we introduced red/orange fluorescent Cdt1 and green fluorescent Geminin into immortalized Apollo F/F MEFs and used FACS for both Cdt1 and Geminin to select cells that had incorporated both constructs into their genomes. The cells, which were in early S phase at the time of the FACS sorting, were replated and infected with Hit&Run Cre to delete Apollo. At 72 hr after Cre, wild-type and Apollo-deficient cells were harvested and sorted again by FACS to isolate Cdt1 + Gem À G1
and Cdt1 À Gem + late S/G2 populations ( Figures S3B and S3C ).
The FACS-sorted cells were plated on coverslips and fixed at different time points after a 30 min BrdU pulse to evaluate their S phase index. The cell-cycle profile of the Cdt1 + Gem À cells, either immediately after sorting or 1.5 hr after plating, showed distinct 2N and 4N peaks with few cells containing intermediate DNA content ( Figure 3B and Figure S3C ). The low percentage of BrdU-positive cells confirmed that most cells were not in S phase. Given the high incidence of tetraploid cells in the asynchronous Apollo F/F MEFs ( Figure S1B ), the 4N peak of the Cdt1 + Gem À G1 cells likely reflects tetraploid cells in G1 rather than diploid G2 cells. At 6-8 hr after the sorted Cdt1 + Gem À G1 cells were plated, the cell-cycle profile showed a large percentage of cells progressing into S phase, exhibiting $40% BrdU incorporation and increased DNA content ( Figure 3B ).
The cell-cycle profiles of Cdt1
À Gem + late S/G2 cells, both upon sorting and at 1.5 hr after plating, contained a large number of cells nearing either a 4N or an 8N DNA content, and $70% of the cells incorporated BrdU ( Figure 3B , Figure S3C ). The different populations had similar cell-cycle profiles in the presence and absence of Apollo. Using the FUCCI-sorting method, we found that the TIFs seen in the absence of Apollo occurred in early/mid S phase ( Figures  3C and 3D ). Whereas the percentage of TIF-positive G1 or late S/G2 cells did not increase, Apollo-deficient cells in mid S phase had a strikingly higher TIF response than did the controls (Figure 3D) . Thus, the absence of Apollo results in a telomeric DNA damage signal in early/mid S phase. Consistent with this conclusion, the TIFs induced by Apollo deletion were primarily found in cells in which many of the TTAGGG repeat signals were paired (Figure 2A ), suggestive of recent telomere replication.
TRF2-F120A Reproduces the ATM Signaling Phenotype of Apollo Loss
In an alternative approach to assess the role of Apollo at telomeres, we generated an allele of mouse TRF2 with a phenylala- nine-to-alanine point mutation at amino acid 120, the conserved residue required for the interaction between human TRF2 and Apollo . Coimmunoprecipitation (coIP) of cotransfected mouse Apollo and TRF2-F120A confirmed that the F120A mutation abolished the interaction between the proteins, as previously reported for the human orthologs ( Figure S1C ). TRF2-F120A or wild-type TRF2 was introduced into TRF2
À/À MEFs and the endogenous TRF2 was deleted with Cre. TRF2-F120A was overexpressed to the same level as the exogenous wild-type TRF2 ( Figure 4A ) and colocalized with TRF1 at telomeres ( Figure 4B ). While cells lacking TRF2 exhibited a severe defect in proliferation, TRF2-F120A rescued this growth defect to a similar extent as wildtype TRF2 ( Figure 4C ). This result is consistent with the ability of TRF2-F120A to repress the frequent telomere fusions associated with TRF2 deletion (see below).
We examined the ability of TRF2-F120A to suppress the ATMmediated DNA damage response induced in the absence of TRF2. Whereas TRF2 deletion resulted in 80%-90% cells with TIFs at most telomeres, expression of the TRF2-F120A mutant reduced the percentage of TIF-positive cells by approximately 2-fold, and the remaining TIF-positive cells had fewer TIFs per cell ( Figures 4D and 4E) . Expression of TRF2-F120A also diminished the level of Chk2 phosphorylation elicited by TRF2 deletion ( Figure 4A) . Notably, however, the fraction of cells with five or more TIFs in the presence of TRF2-F120A remained significantly greater than when TRF2-deficient cells were complemented with wild-type TRF2 ( Figures 4D and 4E to fixation. Telomeres are detected using a FISH probe (green). DNA damage sites are marked with 53BP1 (red). DNA is counterstained with DAPI (blue).
(D) Quantification of the TIF response in G1, early/mid S, and late S phase as assayed in (C). Values are the mean of three independent experiments (>60 nuclei per experiment) and SDs. P values were determined using paired Student's t test. See also Figure S3 .
be able to demonstrate that the phenotypes of TRF2-F120A and Apollo loss are indeed identical.
TRF2-Bound Apollo Prevents Fusion of Leading-End Telomeres
We next determined whether the telomere dysfunction induced by Apollo deletion is associated with aberrant DNA repair at telomeres. Apollo-deficient MEFs showed a distinctive telomere fusion phenotype on metaphase spreads ( Figure 5 ). Although the telomere fusions were five to ten times less frequent compared to when TRF2 is deleted, the fusion phenotype of Apollo-deficient cells was highly significant. Strikingly, the telomere fusions observed between 84 and 120 hr after introduction of Cre were nearly all of the chromatid type, indicating a postreplicative fusion event ( Figure 5A ). Later time points included chromosome-type fusions that were most likely due to duplication of chromatid-type fusions after their segregation into daughter cells (data not shown). These secondary chromosome-type fusions were not likely to reflect the function of Apollo, and their incidence was affected by the proliferation rate of the cells. Therefore, later time points after Apollo deletion were not analyzed. Leading-strand and lagging-strand DNA synthesis generates two distinct types of telomeres that could be vulnerable to postreplicative fusions. To determine whether Apollo was important for the protection of both types of telomeres, we used chromosome-orientation fluorescence in situ hybridization (CO-FISH; Bailey et al., 2001) to distinguish between telomere ends generated by leading-and lagging-strand DNA synthesis (referred to as leading-end and lagging-end telomeres). CO-FISH analysis of the Apollo null cells showed that the fusions exclusively involved telomeres generated by leading-strand DNA synthesis (shown in red) ( Figures 5C-5E ). Thus, Apollo has a specific role in protecting leading-end telomeres, resulting in chromatid-type fusions when Apollo is absent. The absence of sister fusions suggests that the lagging-end telomeres remain protected in Apollo-deficient cells. The function of Apollo in protecting leading-end telomeres required its localization at telomeres. The ApolloDTRF2 mutant was unable to prevent leading-end telomere fusions ( Figures  5C-5E ). Similarly, expression of TRF2-F120A resulted in a significant level of leading-end telomere fusions observed by CO-FISH, while this mutant was fully capable of repressing the chromosome-type fusions associated with TRF2 deletion (Figures 5C-5E ).
In addition, the nuclease activity of Apollo was involved in protecting the leading-end telomeres. Cells expressing Apollo-ND instead of wild-type Apollo generated a statistically significant level of leading-end telomere fusions after deletion of endogenous Apollo ( Figure 5D ). A more severe phenotype was observed with a second nuclease domain mutant (ApolloD31-37, removing the HxHxDH motif in the metallo-b-lactamase domain and also containing the H230A mutation), which was expressed at similar levels as wild-type Apollo and retained its interaction with TRF2 ( Figure S4 and data not shown) but was incapable of repressing leading-end telomere fusions ( Figure 5D ). The difference between the two nuclease mutants is discussed below.
Apollo Contributes to Maintenance of the Telomeric Overhang
To determine whether the aberrant DNA damage response at leading-end telomeres was due to a change in the terminal telomeric structure, we assessed the telomeric overhang in the absence of Apollo. At 5 days after Cre-mediated deletion of Apollo, we observed a 30%-40% reduction in the relative telomeric overhang signal (Figures 6A and 6B ). Assuming equal Figure S4 .
overhang lengths at lagging-and leading-end telomeres, complete loss of the overhang from leading-end telomeres would be expected to result in a 50% drop. Therefore, we consider the observed 30%-40% reduction in overhang signal an indication of a considerable defect in overhang maintenance. The overhang phenotype was rescued by full-length wild-type Apollo but not by ApolloDTRF2 or Apollo-ND ( Figures 6A and  6B) . Similarly, when the TRF2-F120A mutant was expressed in TRF2 F/-p53 À/À MEFs, the relative telomeric overhang signal was approximately 30% less than in the presence of wild-type TRF2 ( Figures 6C and 6D ). Since TRF2-F120A represses most of the telomere fusions resulting from TRF2 deletion ( Figure 5E ), this overhang loss cannot be ascribed to processing by NHEJ.
More likely, the diminished overhang signal in the TRF2-F120A setting is due to the lack of recruitment of Apollo to telomeres. In the presence of telomerase, the overhangs can be elongated transiently due to the uncoupling of telomerase action, which occurs throughout S phase, and C-strand fill-in, which is delayed until late S/G2 (Zhao et al., 2008) . To exclude that the change in overhang signal was due to an effect of Apollo on telomerase, we generated TRF2 reduction in overhang signal ( Figures S5A-S5D) . Furthermore, the cells showed the same induction of leading-end telomere Cre and at 120 hr after Cre. FUCCI-sorted cells were immediately embedded in agarose plugs for overhang analysis as in (A). The relative single-stranded signal was normalized to total TTAGGG signal and determined as a percentage of the signal in the lane containing G1 cells without Cre (set at 100). (F) Quantification of relative single-stranded telomeric signal in G1 and late S/G2 as assayed in (E). The single-stranded telomeric signal was normalized to total TTAGGG signal and determined as a percentage of the signal in G1 cells without Cre (set at 100). Values are the means of three independent experiments and SDs. P values were determined by paired Student's t test. See also Figure S5. fusions observed when TRF2-F120A replaced the endogenous TRF2 in telomerase-positive cells (Figures S5E and S5F ). This result indicates that Apollo regulates the G overhang in a manner that is independent of telomerase.
We next analyzed the overhang signal in Apollo null cells at different phases of the cell cycle using the FUCCI-sorting system described above. Both wild-type and Apollo-deficient cells experienced a transient increase in overhang signal in late S phase. This Apollo-independent increase in overhang signal during progression from G1/early S to late S phase could arise from extension of the G-rich overhang by telomerase and/or resection of the C-rich strand by other nucleases. However, compared to wild-type cells, Apollo-deficient cells showed a 40% reduction in telomeric overhang signal regardless of the cell-cycle phase ( Figures 6E and 6F, Figure S5G ).
DISCUSSION
These data reveal that TRF2-bound Apollo functions at replicating telomeres, promoting the maintenance of the telomeric overhang, repressing S phase-specific ATM signaling, and protecting leading-end telomeres from fusion. Based on these results, we propose a model in which TRF2 recruits the Apollo nuclease to process leading-end telomeres immediately after their replication. If this processing does not occur or is delayed, the leading-end telomeres would remain blunt, making them vulnerable to end-joining reactions and exposing the telomere end in a manner that activates the MRN/ATM pathway. These findings establish that, as was generally assumed, maintenance of the telomeric overhang is important for the protection of mammalian telomeres.
The action of Apollo at telomeres requires its association with TRF2, as an allele of Apollo lacking the TRF2 binding site is nonfunctional, and cells expressing a TRF2 allele that does not bind Apollo have the same telomere phenotypes as Apollo-deficient cells. We also conclude that the nuclease activity of Apollo is required for its function, since the Apollo null phenotypes are not rescued by Apollo-ND, in which essential residues of the nuclease domain have been mutated. Although Apollo-ND appears to be a null allele with regard to overhang maintenance and repression of ATM signaling, its ability to repress the leading-end telomere fusions, while weaker than for the wildtype Apollo, is not nil. In contrast, a second nuclease-deficient allele of Apollo, lacking the HxHxDH motif in the metallo-b-lactamase domain, completely fails to protect leading-end telomeres from fusions. One explanation for this discrepancy is that the Apollo-ND allele has residual nuclease activity that is sufficient to protect leading-end telomeres during the short time period in S/G2 when they are vulnerable to fusion. This residual nuclease activity would have to be very minor because there is no overt difference in the overhang signal compared to Apollo deletion. Another possibility is that the Apollo protein itself protects the leading-end telomeres from fusion. Such protection could conceivably involve the nuclease domain in a manner that is destroyed by deletion of amino acids 31-37 but preserved in Apollo-ND despite the point mutations. It will therefore be of interest to study the nuclease and end-binding activities of TRF2-Apollo complexes in vitro.
As Apollo has been implicated in ICL repair (Demuth et al., 2004; Bae et al., 2008) , the appearance of S phase TIFs in the absence of Apollo could alternatively be explained by an inability to repair lesions encountered during telomere replication. We do not favor this explanation because the major phenotypes observed in the absence of Apollo are not associated with aphidicolin-induced replication stress or deletion of the shelterin component TRF1. Replication fork stalling prior to collapse is often associated with accumulation of single-stranded DNA and activation of the ATR kinase, which we do not observe in Apollo null cells. Furthermore, deletion of Apollo in mouse cells does not induce the fragile telomere phenotype associated with telomere replication problems ). Although we have not formally excluded contributions of telomeric Apollo in repairing lesions encountered by the replication machinery, the major phenotypes observed at telomeres lacking Apollo are inconsistent with the prevention of replication stress being a primary function of Apollo at telomeres.
The role of Apollo at replicating telomeres is distinct from previously characterized functions of the core components of shelterin. The predominance of leading-end telomere fusions in the Apollo knockout cells contrasts with both the TRF2 and POT1a/b knockout phenotypes. Although TRF2 deletion induces occasional chromatid-type fusions, most of the fusions in TRF2 null cells occur in G1 and manifest as chromosome-type fusions in the subsequent metaphase (Celli and de Lange, 2005; Konishi and de Lange, 2008) . POT1a/b deletion results in sporadic chromosome-type fusions and postreplicative fusions involving sister telomeres (Hockemeyer et al., 2006) . Neither chromosome-type fusions nor sister fusions are observed in Apollo null cells. Thus, whereas TRF2 and POT1a/b function at both leading-and lagging-end telomeres, Apollo acts specifically in the protection of leading-end telomeres.
Our results suggest that the protective role of Apollo is limited to S phase. In the absence of Apollo, telomeres experience a transient DNA damage response mainly in S phase despite a persistent overhang defect throughout the cell cycle. Furthermore, we do not observe the chromosome-type fusions that would result if leading-end telomeres continued to be vulnerable to fusion in daughter cells. How the protected state is restored as cells progress through mitosis remains unknown. One possibility is that intrinsic properties of telomeres allow protection of unprocessed ends in G1 but not in S phase. For instance, leading-end telomeres with short overhangs might still form t-loops at a slower rate. Another possibility is that additional Apollo-independent processing in late S/G2 could be sufficient to restore end protection. Indeed, the overhang signal transiently increases in late S/G2 in both wild-type and Apollo-deficient cells. This is presumably due to 5 0 resection by other nucleases or elongation of the overhang by telomerase, which is uncoupled from fill-in synthesis of the C-rich strand (Zhao et al., 2009 ). Finally, it is possible that the milieu of G1 and S phase cells exposes telomeres to different threats, requiring distinct protective measures to ensure telomere protection in these different stages of the cell cycle.
We previously proposed that the F120 site in TRF2 not only provides a docking site for Apollo but also recruits additional shelterin accessory factors, such as Nbs1, XPF, PARP1, ATM, and ATR Palm and de Lange, 2008) . There would be no competition for this docking site because TRF2 is very abundant at telomeres, whereas most shelterin accessory factors are not (Takai et al., 2010) . The versatility of the F120 docking site was supported by the identification of two proteins, PNUTS and MCPH1, which can bind to TRF2 using the YxLxP motif (Kim et al., 2009) . However, our current data now cast doubt on the importance of the F120 docking site beyond the interaction with Apollo. The phenotype of the TRF2-F120A mutant is mild, showing the limited DNA damage response phenotype and telomere fusions associated with Apollo loss but no additional telomere dysfunction. Although it is possible that the other F120-interacting factors are dispensable for telomere protection (for instance, due to redundancy), our data warrant further testing of the concept of the common F120 docking site.
The main conclusion from the observations on Apollo-deficient telomeres concerns the role of the telomeric overhang in telomere protection. The data are consistent with the long-held (but previously unsubstantiated) view that the overhang has a protective role. In particular, leading-end telomeres appear to become resistant to telomere fusions and can avoid activating the ATM kinase pathway if an overhang is formed rapidly. We imagine that the overhang would help in forming the t-loop structure, which is expected to block binding of the MRN DSB sensor in the ATM pathway and prevent loading of the NHEJ factor Ku70/80. In addition, the loading of POT1 proteins on the overhang may be crucial to prevent telomere fusion immediately after telomere replication. Prior data indicated that POT1a/b protects leading-end telomeres (as well as lagging-end telomeres) from fusion. The current data argue that the generation of the appropriate POT1a/b binding sites at leading-end telomeres is mediated (in part) by Apollo.
The findings on Apollo are relevant to the Hoyeraal-Hreidarsson syndrome, a severe variant of the telomere dysfunction disease dyskeratosis congenita (DC). DC is a bone marrow failure syndrome that can be caused by mutations in telomerase components and the shelterin component TIN2, but shelterin accessory factors had not been implicated in the disease (Mason et al., 2005; Savage et al., 2008; Walne et al., 2008) . A recent study identified a single Hoyeraal-Hreidarsson syndrome patient expressing a dominant-negative allele of Apollo that lacks the TRF2-binding domain and induces an ATM-dependent telomere damage signal (Touzot et al., 2010) . However, the Apollo locus appeared to lack a disease-causing mutation. Our findings that Apollo deficiency is specifically associated with defective overhang maintenance and leading-end telomere fusions may facilitate the identification of additional patients with HoyeraalHreidarsson syndrome or other forms of DC that are caused by defects in Apollo.
EXPERIMENTAL PROCEDURES Apollo Gene Targeting
The targeting vector for modification of the mouse Apollo locus was generated in pSL301 by standard cloning techniques using Bac-derived DNA fragments extending from the NheI site upstream of the Apollo gene to the SacI site in the 3 0 UTR. A TK-neomycin cassette flanked by FRT sites and carrying one loxP site was inserted into the PacI site in the third intron of the Apollo gene.
A second loxP site was introduced into the NseI site in intron 1 by insertion of a loxP oligonucleotide that also contained an NsiI site used in genomic analysis of targeted embryonic stem cells (ESCs). ESC clones with the correct integration were identified by genomic blotting of NsiI-digested DNA using a probe upstream of the NheI site, and the presence of a single neo integration was confirmed. Targeted ESCs were used to generate chimeras and offspring with the targeted genotype. The neo cassette was removed using the FLPe deleter mouse strain (Jackson Labs). The resulting Apollo F/+ genotype was maintained on a mixed background (129/C57Bl/6J).
Cell Lines, Plasmids, and shRNAs Apollo F/F MEFs were isolated from E13.5 embryos from Apollo F/+ intercrosses and immortalized at passage 2 with pBabeSV40-LT (a gift from Greg Hannon). Cells were maintained thereafter in DMEM/10%-15% FBS supplemented with nonessential amino acids, glutamine, and penicillin/streptomycin. Cre recombinase was introduced into immortalized MEFs using two to four rounds of infection (12 hr intervals) with Hit&Run-Cre or pWZL-Cre as described previously (Celli and de Lange, 2005) . For analysis of different time points after infection, t = 0 refers to 12 hr after the first infection with Cre retrovirus. Apollo alleles with an N-terminal FLAG-[HA]2 tag were generated by PCRmediated mutagenesis and expressed using the pLPC puromycin-selectable retroviral vector. Phoenix packaging cells were transfected with the plasmids, and the retroviral supernatant was used for two infections of SV40-LT Apollo tions at 12 hr intervals, followed by 3 days of selection prior to Cre infection. shRNAs for ATR kinase (shATR3-1; Lazzerini Denchi and de Lange, 2007) and ATM kinase (GGAAGTCAAGGAACAACAACTA) were introduced in four infections at 12 hr intervals using the pSuperior hygromycin retroviral vector.
PCR Genotyping and RT-PCR Transcript Analysis
PCR with the following primers was used to monitor Apollo deletion on isolated genomic DNA before and after introduction of Cre: F, ACATCTCCTCATCTTG TCTG; R1, CCTATCATGATAATCCCAGC; R2, CTTGAGGGTTTCTTTTGGAG.
RT-PCR was performed with the oligo-dT ThermoScript RT-PCR system (Invitrogen). RNA was isolated from approximately 10 6 cells with the QIAGEN RNAeasy kit. Two to three micrograms RNA was reverse transcribed with the ThermoScript RT-PCR system (Invitrogen) by using oligo dT priming and the protocol provided by the manufacturer. The primers used for PCR after cDNA synthesis are as follows: Apollo RT1 (forward CACGGTGGGTTTGT CTAGC, reverse GTTGCTCCAGCAGTGATTC), Apollo RT2 (forward CTCC CATCA CTGCTTGCCTC, reverse GCAACTGTACCAACTCCAGG), GAPDH (forward TGAAGGTCGGTGTGAACGGATTTGGC, reverse CATGTAGGCCAT GAGGT CCACCAC), Ap4b1 RT1 (forward GACGATGCCATACCTTGGCTC, reverse GTTCAGTACTTCAGCCTG), and Ap4b1 RT2 (forward GACGATGCCA TACC TTGGCTC, reverse CTGCTCTTGAGATAGCTGTC).
Immunofluorescence, Immunoblotting, and Immunoprecipitation For IF/IF-FISH, immunoblotting, and coIP, previously described methods were used (Celli and de Lange, 2005; Dimitrova et al., 2008; Chen et al., 2008) with the following antibodies: HA.11, Covance; myc, 9B11 (IB, IF) and 9E10, Sigma (IP); FLAG, M2; a-tubulin, Sigma; g-tubulin, GTU88; Chk2, BD Transduction; TRF1 (mouse), #644; TRF2, #647; 53BP1, 100-304, Novus; ATM, Mat3, Sigma; ATR, FRP goat, Santa Cruz N-19. For IF detection of Apollo, cells were extracted for 90 s with Triton X-100 buffer (0.5% Triton X-100, 20 mM HEPES-KOH [pH 7.9], 50 mM NaCl, 3 mM MgCl 2 , 300 mM sucrose) prior to fixation with 3% paraformaldehyde/2% sucrose.
Analysis of Telomeric DNA by In-Gel Hybridization, FISH, CO-FISH
Telomeric overhang signals and telomeric restriction fragment patterns were determined by in-gel hybridization with an end-labeled 32 P-(AACCCT) 4 telomeric oligonucleotide as previously described (Celli and de Lange, 2005) .
